Issam I El Naqa

Title: Innovations in Radiotherapy: The Contributions of Issam I El Naqa

Introduction

Issam I El Naqa is an accomplished inventor based in Ann Arbor, MI. He has made significant contributions to the field of radiotherapy through his innovative work on optical probes. His research focuses on enhancing the quality assurance of radiotherapy treatments, particularly in tracking tumors during external beam radiation therapy.

Latest Patents

Issam I El Naqa holds a patent for "Silicon photomultiplier array-based multispectral optical probes for image-guided radiotherapy." This invention addresses the challenges of detecting Cerenkov Emission (CE) during external beam radiation therapy (EBRT) from a linear accelerator (Linac). The patent highlights the potential of using silicon photomultipliers (SiPMs) for low light detection, which can significantly improve the sensitivity and flexibility of devices used in complex treatment environments.

Career Highlights

El Naqa's career is marked by his dedication to advancing radiotherapy techniques. His work has been instrumental in developing tools that enhance the detection of tumor molecular status during treatment. By comparing the performance of SiPMs with commercially available silicon photodiodes (PDs), he has contributed valuable insights into the feasibility of these technologies in clinical settings.

Collaborations

Throughout his career, Issam I El Naqa has collaborated with notable colleagues, including Ibrahim Oraiqat and Roy Clarke. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of radiotherapy.

Conclusion

Issam I El Naqa's contributions to the field of radiotherapy through his innovative patents and collaborative efforts have the potential to significantly improve cancer treatment methodologies. His work exemplifies the importance of innovation in enhancing patient care and treatment outcomes.